Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bridges

Showing results (511-520 of 588) with videos related to

Pageof 59
Sort By:
Malaria Journal|January 8, 2016
Targeting indoor residual spraying for malaria using epidemiological data: a case study of the Zambia experienceJessie Pinchoff, David A Larsen, Silvia Renn, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 10, 2019
Disordered Antigens and Epitope Overlap Between Anti-Citrullinated Protein Antibodies and Rheumatoid Factor in Rheumatoid ArthritisZihao Zheng, Aisha M Mergaert, Lauren M Fahmy, et al.
Endocrinology|March 1, 2012
Hematopoetic prostaglandin D synthase: an ESR1-dependent oviductal epithelial cell synthasePhillip J Bridges, Myoungkun Jeoung, Sarah Shim, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2013
Microwave accelerated synthesis of isoxazole hydrazide inhibitors of the system xc- transporter: Initial homology modelAfnan A Matti, Joseph Mirzaei, John Rudolph, et al.
Biochemical and Biophysical Research Communications|August 31, 1992
Nucleotide-activated chloride channels in lysosomal membranesB C Tilly, G M Mancini, J Bijman, et al.
Journal of Medicinal Chemistry|January 5, 1996
Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptorA J Bridges, H Zhou, D R Cody, et al.
The Journal of Clinical Investigation|July 2, 2024
Potentiation of BKCa channels by cystic fibrosis transmembrane conductance regulator correctors VX-445 and VX-121Aaron Kolski-Andreaco, Stefanie Taiclet, Michael M Myerburg, et al.
PNAS Nexus|July 21, 2025
VX-445 (elexacaftor) inhibits chloride secretion across human bronchial epithelial cells by directly blocking KCa3.1 channelsAaron Kolski-Andreaco, Corina M Balut, Matthew D Green, et al.
Molecular and Cellular Biochemistry|October 31, 1975
Regulation of mammalian pyruvate dehydrogenaseR M Denton, P J Randle, B J Bridges, et al.
Journal of Medicinal Chemistry|April 26, 1996
Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptorG W Rewcastle, B D Palmer, A M Thompson, et al.
Pageof 59

Showing results (511-520 of 588) with videos related to

Sort By:
Pageof 59
Malaria Journal|January 8, 2016
Targeting indoor residual spraying for malaria using epidemiological data: a case study of the Zambia experienceJessie Pinchoff, David A Larsen, Silvia Renn, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 10, 2019
Disordered Antigens and Epitope Overlap Between Anti-Citrullinated Protein Antibodies and Rheumatoid Factor in Rheumatoid ArthritisZihao Zheng, Aisha M Mergaert, Lauren M Fahmy, et al.
Endocrinology|March 1, 2012
Hematopoetic prostaglandin D synthase: an ESR1-dependent oviductal epithelial cell synthasePhillip J Bridges, Myoungkun Jeoung, Sarah Shim, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2013
Microwave accelerated synthesis of isoxazole hydrazide inhibitors of the system xc- transporter: Initial homology modelAfnan A Matti, Joseph Mirzaei, John Rudolph, et al.
Biochemical and Biophysical Research Communications|August 31, 1992
Nucleotide-activated chloride channels in lysosomal membranesB C Tilly, G M Mancini, J Bijman, et al.
Journal of Medicinal Chemistry|January 5, 1996
Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptorA J Bridges, H Zhou, D R Cody, et al.
The Journal of Clinical Investigation|July 2, 2024
Potentiation of BKCa channels by cystic fibrosis transmembrane conductance regulator correctors VX-445 and VX-121Aaron Kolski-Andreaco, Stefanie Taiclet, Michael M Myerburg, et al.
PNAS Nexus|July 21, 2025
VX-445 (elexacaftor) inhibits chloride secretion across human bronchial epithelial cells by directly blocking KCa3.1 channelsAaron Kolski-Andreaco, Corina M Balut, Matthew D Green, et al.
Molecular and Cellular Biochemistry|October 31, 1975
Regulation of mammalian pyruvate dehydrogenaseR M Denton, P J Randle, B J Bridges, et al.
Journal of Medicinal Chemistry|April 26, 1996
Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptorG W Rewcastle, B D Palmer, A M Thompson, et al.
Pageof 59